Disulfiram inhibits TNF-alpha-induced cell death

Cytokine. 2000 Sep;12(9):1356-67. doi: 10.1006/cyto.2000.0725.

Abstract

Disulfiram, a clinically employed alcohol deterrent, was recently discovered to inhibit caspase-3 and DNA fragmentation. Using LLC-PK1 cells and murine liver as models, we examined if the drug inhibited TNF-alpha-induced cell death. Disulfiram produced dose-dependent inhibition of TNF-alpha-induced cell death as well as caspase-3-like activity. Disulfiram retained 80% of its effect when added 4 h after TNF-alpha. Disulfiram protected the cells from cytokine-induced death for at least 6 days. The cells rescued by the drug preserved the ability to proliferate. The cells died spontaneously after exposure to TNF-alpha for just 70 min. Co-administration of 15 microM disulfiram and TNF-alpha for 70 min prior to their removal abolished TNF-alpha-induced killing, and this was associated with restoration of mitochondrial membrane potential and suppression of reactive oxygen species. Treatment of mice with TNF-alpha and D-galactosamine for 5 h markedly increased hepatic DNA fragmentation and caspase-3-like activity. Disulfiram at 0.6 mmol/kg abolished these effects. We conclude that disulfiram is a potent inhibitor of TNF-alpha-induced cell death in vitro. The underlying mechanisms include stabilization of mitochondrial membrane potential, suppression of reactive oxygen species, and inhibition of caspase-3-like activity. We further conclude that disulfiram inhibits DNA fragmentation in vivo in association with the blockade of caspase-3-like activity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylcysteine / pharmacology
  • Alcohol Deterrents / pharmacology
  • Amino Acid Chloromethyl Ketones / pharmacology
  • Animals
  • Caspase 3
  • Caspase Inhibitors
  • Cell Death / drug effects*
  • Cell Division / drug effects
  • Cell Line
  • Cysteine Proteinase Inhibitors / pharmacology
  • DNA Fragmentation / drug effects
  • Disulfiram / pharmacology*
  • Dose-Response Relationship, Drug
  • Enzyme Inhibitors / pharmacology
  • Enzyme-Linked Immunosorbent Assay
  • Flow Cytometry
  • Galactosamine / pharmacology
  • In Situ Nick-End Labeling
  • Liver / drug effects
  • Liver / metabolism
  • Male
  • Membrane Potentials / drug effects
  • Mice
  • Mice, Inbred C3H
  • Mitochondria / drug effects
  • Reactive Oxygen Species / metabolism
  • Recombinant Proteins / metabolism
  • Recombinant Proteins / pharmacology
  • Swine
  • Time Factors
  • Tumor Necrosis Factor-alpha / metabolism
  • Tumor Necrosis Factor-alpha / pharmacology*

Substances

  • Alcohol Deterrents
  • Amino Acid Chloromethyl Ketones
  • Caspase Inhibitors
  • Cysteine Proteinase Inhibitors
  • Enzyme Inhibitors
  • Reactive Oxygen Species
  • Recombinant Proteins
  • Tumor Necrosis Factor-alpha
  • benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone
  • Galactosamine
  • Casp3 protein, mouse
  • Caspase 3
  • Disulfiram
  • Acetylcysteine